Trials / Active Not Recruiting
Active Not RecruitingNCT03897491
PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
Evaluation of the Feasibility of PD L 506 for Stereotactic Interstitial Photodynamic Therapy (iPDT) in Adult Patients With Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- photonamic GmbH & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The trial is an open, multicenter, explorative, pilot phase II study in a small number of patients to assess safety and efficacy of stereotactic interstitial photodynamic therapy (iPDT) with PD L 506 in newly diagnosed supratentorial IDH wild-type glioblastoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-aminolevulinic acid | 5-aminolevulinic acid powder for oral solution |
Timeline
- Start date
- 2021-09-03
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2019-04-01
- Last updated
- 2025-05-14
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03897491. Inclusion in this directory is not an endorsement.